Enjoy complimentary customisation on priority with our Enterprise License!
The veterinary clostridium vaccine market size has the potential to grow by USD 158.58 million during 2020-2024, and the market’s growth momentum will accelerate during the forecast period.
This report provides a detailed analysis of the market by end-user (swine, bovine, poultry, and others) and geography (APAC, Europe, MEA, North America, and South America). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including Bioveta AS, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Covetrus Inc., Elanco, Animal Health Inc., LABORATORIOS HIPRA SA, Merck & Co. Inc., Vetoquinol SA, Virbac Group, and Zoetis Inc.
The veterinary clostridium vaccine market is concentrated. Market vendors are acquiring new facilities to synergize their R&D capability and develop new products for target users. Animal Health Inc., LABORATORIOS HIPRA SA, Merck & Co. Inc., Vetoquinol SA, Virbac Group, and Zoetis Inc. are some of the major market participants. Although the dependency on livestock products will offer immense growth opportunities, manufacturing and storage issues will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by End-user
Customer landscape
Geographic Landscape
Drivers, Challenges, and Trends
Vendor Landscape
Vendor Analysis
Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
Get the report (PDF) sent to your email within minutes.